| Lipohypertrophy in China: prevalence, risk factors, insulin consumption, and clinical impact L Ji, Z Sun, Q Li, G Qin, Z Wei, J Liu, AB Chandran, LJ Hirsch Diabetes Technology & Therapeutics 19 (1), 61-67, 2017 | 92 | 2017 |
| Association of three-gene interaction among MTHFR, ALOX5AP and NOTCH3 with thrombotic stroke: a multicenter case–control study J Liu, K Sun, Y Bai, W Zhang, X Wang, Y Wang, H Wang, J Chen, X Song, ... Human genetics 125, 649-656, 2009 | 63 | 2009 |
| Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease C Zhang, L Jiang, L Xu, J Tian, J Liu, X Zhao, X Feng, D Wang, Y Zhang, ... European Heart Journal 40 (41), 3397-3405, 2019 | 57 | 2019 |
| Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicity in vitro Z Liu, X Song, Y Xin, X Wang, H Yu, Y Bai, J Liu, C Zhang, R Hui Chinese medical journal 122 (21), 2652-2656, 2009 | 48 | 2009 |
| A common variant of the eNOS gene (E298D) is an independent risk factor for left ventricular hypertrophy in human essential hypertension Y Xin, X Song, H Xue, Z Liu, X Wang, H Wang, K Sun, Y Bai, J Liu, R Hui Clinical Science 117 (2), 67-73, 2009 | 40 | 2009 |
| Common genetic variation in DDAH2 is associated with intracerebral haemorrhage in a Chinese population: a multi-centre case-control study in China Y Bai, J Chen, K Sun, Y Xin, J Liu, R Hui Clinical Science 117 (7), 273-279, 2009 | 28 | 2009 |
| Implications of hyperuricemia in severe coronary artery disease C Zhang, L Jiang, L Xu, J Tian, J Liu, X Zhao, X Feng, D Wang, Y Zhang, ... The American journal of cardiology 123 (4), 558-564, 2019 | 22 | 2019 |
| Skin and subcutaneous tissue thickness at insulin injection sites in Chinese diabetes patients: clinical implications W Wang, X Guo, G Shen, G Bai, Z Wei, J Liu, L Hirsch, K Strauss Diabetes & Metabolism 42 (5), 374-377, 2016 | 20 | 2016 |
| 主动脉夹层患者临床特征及预后分析研究 刘亚欣， 樊晓寒， 刘卫民， 付长波， 刘峻豪， 宋晓东， 惠汝太 中国分子心脏病学杂志 8 (5), 293-296, 2008 | 18 | 2008 |
| Prognostic value of plasma big endothelin-1 level among patients with three-vessel disease: a cohort study C Zhang, J Tian, L Jiang, L Xu, J Liu, X Zhao, X Feng, D Wang, Y Zhang, ... Journal of Atherosclerosis and Thrombosis 26 (11), 959-969, 2019 | 14 | 2019 |
| LIPOHYPERTROPHY-PREVALENCE, RISK FACTORS, AND CLINICAL CHARACTERISTICS OF INSULIN-REQUIRING PATIENTS IN CHINA L Hirsch, L Ji, Z Sun, Q Li, G Qin, Z Wei, J Liu, L Luan, D Wang, ... DIABETES TECHNOLOGY & THERAPEUTICS 17, A58-A59, 2015 | 13 | 2015 |
| Notch3 基因多态, MTHFR 基因多态和 ALOX5AP 基因多态的多位点联合交互作用显著增加血栓性脑卒中的风险 刘峻豪， 孙凯， 白永怿， 汪一波， 张伟丽， 陈敬洲， 王虎， 宋晓东， 惠汝太 中国分子心脏病学杂志 8 (6), 328-332, 2008 | 13 | 2008 |
| Lipohypertrophy: prevalence, risk factors, clinical characteristics, and economic burden of insulin-requiring patients in China Z Sun, Q Li, L Ji, G Qin, L Hirsch, Z Wei, J Liu, L Luan, D Wang, ... Diabetologia 58, S438-S439, 2015 | 8 | 2015 |
| Lipohypertrophy (LH) prevalence varies widely between chinese cities-need for consistent LH diagnostic methods Q Li, L Ji, Z Sun, G Qin, Z Wei, J Liu, L Luan, L Hirsch Diabetes 64, A692-A692, 2015 | 8 | 2015 |
| 多因素降维法介绍及其在复杂疾病研究中的应用 刘峻豪， 惠汝太 中国分子心脏病学杂志 8 (4), 236-239, 2008 | 5 | 2008 |
| Protective effect of chrysoeriol against doxorubicin-induced cardiotoxicityin vitro L Zhe, X SONG, X Ying, X WANG, Y Hui, Y BAI, J LIU, C ZHANG, R HUI Chinese Medical Journal 122 (21), 2652-2656, 2009 | 4 | 2009 |
| 糖尿病大鼠心肌梗死后易发心力衰竭的机制 裴汉军， 宋光远， 王浩， 吴伟春， 刘峻豪， 吴永健 中国分子心脏病学杂志 8 (5), 269-276, 2008 | 4 | 2008 |
| VEGF2 型受体基因多态与脑卒中易感性和脑卒中复发相关 万鲁虹， 张伟丽， 孙凯， 刘峻豪 中国分子心脏病学杂志 9 (4), 204-208, 2009 | 3 | 2009 |
| 大内皮素-1 评价特发性肺动脉高压严重程度和预后的研究 陶新曹， 倪新海， 柳志红， 何建国， 熊长明， 张健强， 刘峻豪 中国分子心脏病学杂志 9 (1), 31-33, 2009 | 2 | 2009 |
| Economic and patient burden of Lipohypertrophy in Chinese patients with Diabetes A Chandran, S DiMario, L Hirsch, Q Li, Z Sun, L Ji, G Qin, S Wei, J Liu, ... Value in Health 18 (3), A51, 2015 | 1 | 2015 |
